Kidney Disease Research Updates
NIDDK Advisory Council Member Receives 2011 Physician Clinician in Diabetes Award
Adapted from the University of Washington Office of News and Information
Dr. Jerry P. Palmer
Dr. Jerry P. Palmer, professor of medicine, has received the American Diabetes Association’s prestigious 2011 Outstanding Physician Clinician in Diabetes Award. The award was presented at the Association’s 71st Scientific Sessions in San Diego, Calif.
The Outstanding Physician Clinician in Diabetes Award is given to an individual who has made major contributions to diabetes care as a widely respected clinician and educator.
Palmer is a member of the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and is the director of the UW Diabetes Endocrinology Research Center and chief of the Division of Endocrinology, Metabolism, and Nutrition, Puget Sound Veterans Affairs Health Care System. Palmer has a distinguished career as clinician, educator, mentor, and scientist.
Known internationally for his discovery of insulin autoantibodies, Palmer also is highly regarded locally as a clinician, in part because he implements research findings to help patients.
Palmer was a principal investigator of the Seattle Diabetes Control and Complications Trial (DCCT) site. Realizing the importance of the multidisciplinary approach, he created the UW Diabetes Care Center. This clinic has an international reputation as a premier academic diabetes center. Palmer is also a clinician and teacher in the Puget Sound Veterans Affairs Health Care System’s Endocrine Clinic, a popular training site for UW students, residents and fellows.
Palmer is a past recipient of the Robert H. Williams Rachmiel Levine Award and has been repeatedly named among the Best Doctors in America. He is a past president of the Immunology of Diabetes Society.
He has served on the board of the American Diabetes Association’s Washington affiliate (1975-1983), and on its national board (1994-1997). He was on the National Institutes of Health steering committee for the Diabetes Prevention Trial–Type 1 (DPT-1) and now for Type 1 Diabetes TrialNet, and is on the international executive committee for TRIGR (Trial to Reduce Insulin Dependent Diabetes in the Genetically at Risk).
NIH Publication No. 12–4531
Page last updated June 26, 2012